Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hope Biosciences Research Foundation
Pharmacyclics LLC.
Kyowa Kirin Co., Ltd.
Fate Therapeutics
Alexion Pharmaceuticals, Inc.
Pharmacyclics LLC.
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Genta Incorporated
Genta Incorporated